North, certainly Pfizer is not out of it completely. But their message in that articles seemed to indicate they were in a "cooling off period" from M&A.
But if they are waiting until after the results of BRAVE, that could be another year+ easily. We will likely (hopefully?) see MITIGATE this fall. But I'm not sure what that trial is going to do for us that we don't already know.